Rapid-acting and Regular Insulin are Equal for High Fat-Protein Meal in Individuals with Type 1 Diabetes Treated with Multiple Daily Injections

Diabetes Therapy, Jan 2018

Introduction The fat and protein content can impact late postprandial glycemia; therefore, prolonged insulin boluses for high-fat/-protein meals are recommended for patients with type 1 diabetes on insulin pump therapy. It is not clear how to translate these findings to multiple daily injection (MDI) therapy. We hypothesized that regular insulin with a slower onset and a longer duration of action might be advantageous for such meals. Methods Twenty-five patients with well-controlled type 1 diabetes (mean HbA1c 6.8%, 51 mmol/mol, no episodes of hypoglycemia) on MDI therapy, aged 27.9 ± 4.3 years and well trained in flexible intensive insulin therapy, were given three test breakfasts with the same carbohydrate (CHO) content. The amount of fat and protein was low (LFP) or high (HFP). For LFP meals, patients received a rapid-acting insulin; for HFP meals, a rapid-acting or regular insulin was given in individual doses according to the CHO content and individual insulin-CHO ratios. Postprandial glycemia was determined by 6-h continuous glucose monitoring. Results Acute postprandial glucose levels measured for 2 h were similar after LFP and two HFP meals (7.8 ± 2.0, 8.1 ± 2.1, 8.0 ± 1.9 mmol/l). Late postprandial glycemia measured from 2 to 6 h was significantly lower after the LFP meal (6.7 ± 1.8 mmol/l, p < 0.05) than after the HFP meals, but there was no difference between the rapid-acting or regular insulin on HFP days (8.6 ± 2.6 and 8.9 ± 2.8 mmol/l, NS). Conclusion The preliminary results of this study indicate no benefit to cover fat-protein meals with regular insulin in individuals with type 1 diabetes treated with MDI.

A PDF file should load here. If you do not see its contents the file may be temporarily unavailable at the journal website or you do not have a PDF plug-in installed and enabled in your browser.

Alternatively, you can download the file locally and open with any standalone PDF reader:

https://link.springer.com/content/pdf/10.1007%2Fs13300-017-0364-2.pdf

Rapid-acting and Regular Insulin are Equal for High Fat-Protein Meal in Individuals with Type 1 Diabetes Treated with Multiple Daily Injections

Rapid-acting and Regular Insulin are Equal for High Fat-Protein Meal in Individuals with Type 1 Diabetes Treated with Multiple Daily Injections 0 K. Safranow Department of Biochemistry and Medical Chemistry, Pomeranian Medical University in Szczecin , Szczecin , Poland 1 K. Jabłon ́ ska P. Mole ̨da (&) L. Majkowska Department of Diabetology and Internal Medicine, Pomeranian Medical University in Szczecin , Police , Poland Introduction: The fat and protein content can impact late postprandial glycemia; therefore, prolonged insulin boluses for high-fat/-protein meals are recommended for patients with type 1 diabetes on insulin pump therapy. It is not clear how to translate these findings to multiple daily injection (MDI) therapy. We hypothesized that regular insulin with a slower onset and a longer duration of action might be advantageous for such meals. Methods: Twenty-five patients with well-controlled type 1 diabetes (mean HbA1c 6.8%, 51 mmol/mol, no episodes of hypoglycemia) on MDI therapy, aged 27.9 ± 4.3 years and well trained in flexible intensive insulin therapy, were given three test breakfasts with the same carbohydrate (CHO) content. The amount of fat and protein was low (LFP) or high (HFP). For LFP meals, patients received a rapid-acting insulin; for HFP meals, a rapid-acting or regular insulin was given in individual doses according to the CHO content and individual insulin-CHO ratios. Postprandial glycemia was determined by 6-h continuous glucose monitoring. Results: Acute postprandial glucose levels measured for 2 h were similar after LFP and two HFP meals (7.8 ± 2.0, 8.1 ± 2.1, 8.0 ± 1.9 mmol/l). Late postprandial glycemia measured from 2 to 6 h was significantly lower after the LFP meal (6.7 ± 1.8 mmol/l, p0.05) than after the HFP meals, but there was no difference between the rapid-acting or regular insulin on HFP days (8.6 ± 2.6 and 8.9 ± 2.8 mmol/l, NS). Conclusion: The preliminary results of this study indicate no benefit to cover fat-protein meals with regular insulin in individuals with type 1 diabetes treated with MDI. Fat-protein meal; Insulin; Multiple daily injection therapy; Type 1 diabetes INTRODUCTION Meal carbohydrate counting is widely used in individuals with type 1 diabetes on functional intensive insulin therapy treated with a basalbolus insulin regimen by means of multiple daily injections (MDI) or continuous subcutaneous insulin infusion (CSII) by insulin pumps. Advanced carbohydrate counting is recommended by official guidelines for type 1 diabetes treatment [ 1 ]. The prandial dose of rapid-acting insulin is based on the amount of carbohydrates in the meal to be consumed (in grams or carbohydrate exchangers) and an individualized insulin-to-carbohydrate ratio (ICR, units/g) [2]. In clinical practice, the meal carbohydrate amount is usually regarded as the most important determinant of the acute postprandial blood glucose level. Glycemia typically peaks within 60–90 min following a carbohydrate-based meal [3]. Recent studies have shown that the fat and/ or protein content can impact late postprandial glycemia, and the effect of both nutrients is additive [4–6]. After a meal high in protein and fat added to a constant amount of carbohydrate, the peak of glycemia is similar in time but accentuated, and prolonged glucose excursions are observed from 3 to 6 h after the meal [6, 7]. These findings point to the need for prolonging insulin delivery with or without an increase in total mealtime insulin dosage [ 7–11 ]. The latest American Diabetes Association recommendations suggest that selected subjects with type 1 diabetes who have mastered carbohydrate counting should be educated on the impact of fat and protein on the glycemic profile [1]. All described strategies of combined carbohydrate, fat and protein counting and application of prolonged insulin boluses for mixed meals are appropriate for patients on CSII. Until now, there has been no attempt to solve the problem of adjustment of insulin for a meal with increased fat and protein content in patients treated with MDI who constitute the majority of patients with type 1 diabetes. The proposed but not verified methods for high-fat/ high-protein meals in this group of patients are to inject an additional dose of rapid-acting insulin 1 h after the meal or to cover the meal with regular insulin [ 12, 13 ]. The main aim of study was to check if regular human insulin, which has a slightly later peak but also a longer total duration of activity, administered before a high-fat-protein meal, would give lower and more stable glycemia than a rapid-acting insulin analog used routinely in patients with type 1 diabetes treated with flexible MDI therapy. The additional aim was to evaluate whether the ICRs calculated in real life (typically for mixed meals) may lead to hypo- or hyperglycemia when used for carbohydrate or high-fat/protein meals. METHODS This study included 25 patients with type 1 diabetes, 14 females and 11 (...truncated)


This is a preview of a remote PDF: https://link.springer.com/content/pdf/10.1007%2Fs13300-017-0364-2.pdf

Karolina Jabłońska, Piotr Molęda, Krzysztof Safranow, Lilianna Majkowska. Rapid-acting and Regular Insulin are Equal for High Fat-Protein Meal in Individuals with Type 1 Diabetes Treated with Multiple Daily Injections, Diabetes Therapy, 2018, pp. 1-10, DOI: 10.1007/s13300-017-0364-2